Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facility 06 May
Lilly's Omvoh is the first and only IL-23p19 to demonstrate durable disease clearance in ulcerative colitis through four years 05 May
